The Georgetown Phase I study was only able to find nine suitable patients with MS who had sufficiently stable types of the illness to make conducting a research study worthwhile. Even then, four patients had to drop out of the study because of the effects of their disease or because of possible intensified progression of the disease. While three of the remaining five reported improvements in their condition, or 60 about percent, the numbers were too small to declare the treatment effectual. As the treatment does not promise a 'cure,' merely alleviation of symptoms, this too presents a problem given the study participant's symptoms were of pain, stiffness or tingling or weakness of their extremities. "We, however, could not objectively quantify improvements in symptoms such as pain and tingling," admitted the main researcher in charge of the study (Haran 2004).
Yet for seemingly every damming study, or inconclusive study, there are anecdotal accounts like 'Marie,' a Toronto woman who swears by the treatment and states that it helped her transition from a wheelchair to a walker and dramatically...
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now